This is a cache of https://www.uibk.ac.at/projects/dp-ardre/ardre-training/ardre-extra-training.html.en. It is a snapshot of the page at 2024-11-20T21:24:24.067+0100.
ARDRE Extra Training – University of Innsbruck

ARDRE extra training


Additional Training

ARDRE research oriented transferable skills 

ARDRE PhD students benefit from the interdisciplinary nature of the programme, covering the disciplines of biology, chemistry and pharmacy. They have access to methods and equipment available in the two Faculties, thereby receiving training in state-of-the-art research skills way beyond their own discipline. In some cases, it is envisaged to create multi-disciplinary projects involving different research teams from different Departments and finally, ARDRE offer possibilities for laboratory rotations.

ARDRE PhD students receive professional training in a commercial environment. Excellent options for inter-sectorality are given by close collaborations between ARDRE-FMs and commercial entities active in drug development, target characterisation and related technologies. The following modalities of professional training will be developed:

  • PhD students working in ARDRE labs perform high-quality research on biological pathways relevant for ageing research and/or regeneration research using the typical academic technologies according to the state-of-theart, e.g. gene inactivation studies basically working within a typical laboratory environment using cell lines, three-dimensional cell culture models or model organisms. To enable the performance of such candidates in a commercial environment, ARDRE PhD students are going be sent to appropriate companies from the ARDRE ancillary network where they will gain the complementary expertise related to drug research, such as screening for small molecule inhibitors of selected biological or biochemical processes, followed by training in the development of lead compounds and their use in clinical studies. Fellows in this part of the programme are going to become acquainted with the industrial culture and project development.

  • ARDRE PhD students working laboratories dealing with drug development and the identification of bioactive compounds will be seconded to top level academic institutions in the ARDRE ancillary network, such as world class universities in which they will be trained in high-profile biomedical research using state-of-the-art model systems where bioactive compounds can be applied for a therapeutic or preventive benefit.

  • The ARDRE secondment programme consists in the secondment of professionals from commercial partners to teach entrepreneurship, industrial working culture, and economic thinking to ARDRE PhD students in focused teaching activities. Both types of activity will significantly enhance the inter-sectorality of the advanced training of the PhD students and provide the basis for extensive networking during the PhD work as well as networking and job options once the PhD thesis has been finished.

ARDRE non-research-oriented transferable skills

The inter-sectoral exposure of the PhD students are enhanced by training in non-academic transferable skills. ARDRE is going to invite experts working in industry or the non-academic sector to deliver courses in entrepreneurship, exploitation of research results, open science, ethics and patenting tailored for the recruited researchers. ARDRE provides networking events, e.g., summer schools, where the doctoral researchers will be able to present their work. During their secondments, ARDRE students will be mentored by experts from the non-academic sector. Moreover, networking with the international scientific community is envisaged a major determinant of an ESR's success. ARDRE support their PhD students to participate in international symposia and workshops to present their own data and to network with the international community. 

Please find more information under our ARDRE special seminars. 


Funding

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 847681.

Co-funded by the European Union

Nach oben scrollen